This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Mar 2011

Takeda & KINAXO Extend Research Deal

A second collaboration has been entered between German KINAXO and Japanese Takeda with the focus on drug development.

KINAXO Biotechnologies GmbH, based in Munich, has reached a second collaboration with Takeda Pharmaceutical Co.. Under the agreement, KINAXO will apply its PhosphoScout technology to assist research of Takeda’s drugs under development. The goal of the collaboration is to allow Takeda to make early decisions on drug efficacy and safety.

PhosphoScout enables quantitative analysis of cellular phosphoproteomes on a global scale and provides valuable insights into a drug’s mode of action. PhosphoScout can also identify differentially regulated phosphorylation sites in vivo that may serve as pharmacodynamic or drug response biomarkers in clinical trials.


Related News